Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCRX.L Regulatory News (CRX)

  • There is currently no data for CRX

Trading Statement

12 Oct 2007 07:00

Cyprotex PLC12 October 2007 Cyprotex PLC (the "Group" or "Cyprotex") NEWS 12 October 2007 Trading Update : Building Confidence The Director's confidence with Cyprotex's core operations continued to buildduring the third quarter of 2007. The Group enters the final three months ofits year on an optimistic note. Historically the final quarter has been the strongest period of Cyprotex'sfinancial year. Moreover, management is pleased to confirm that its customerbase has continued to expand rapidly. Included within the high number of newMSA (Master Services Agreements) recently signed, and taking the Group's 'activecustomer list' beyond 150 pharmaceutical and biotech companies, are severalinternational majors. Strict confidentiality agreements preclude Cyprotex fromnaming individual clients, but the company can now confirm it is currentlycontracted to work for six out of the world's 'top ten' global pharmaceuticalcompanies. The scale and visibility that strong working relationships with suchpartners are capable of providing, is key to proving Cyprotex's business plan.The management is pleased to report an exceptional level of repeat business,while also being asked to tenders for more long-term contract work as well asproject specific collaborations. Cyprotex presently holds an adequate cash resource whilst also retaining asignificant, unused banking facility. Based on current momentum, managementsees the opportunity for modest cash generation to expand this 'cushion' stillfurther during the final three months of the 2007. For further information: Cyprotex PLCRobert Morrison Atwater, CEORussell Gibbs, CFOTel: +44 (0)1625 505 100ir@cyprotex.comwww.cyprotex.com Numura Code Securities LimitedCharles Walker, Corporate FinanceTel: +44 (0)20 7776 1200cew@nomuracode.comwww.nomuracode.com Media Enquires: WMC CommunicationsSimon MillerTel: +44 (0)20 7930 9030simon.miller@wmccommunications.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
5th Aug 20169:30 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
4th Aug 20169:37 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
4th Aug 20169:23 amRNSForm 8.3 - Cyprotex PLC
3rd Aug 201611:23 amBUSForm 8.3 - Cyprotex Plc
3rd Aug 20169:42 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
2nd Aug 20169:19 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
2nd Aug 20167:00 amRNSInterim Results
1st Aug 20169:32 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
29th Jul 20169:29 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
28th Jul 20169:54 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
27th Jul 20169:35 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
25th Jul 20169:10 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
22nd Jul 20169:25 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
21st Jul 20169:56 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
20th Jul 201612:41 pmRNSTrading Update
19th Jul 20169:36 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
18th Jul 20169:32 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
15th Jul 20169:13 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
14th Jul 20169:33 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
12th Jul 201610:12 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
11th Jul 20169:38 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
7th Jul 20167:00 amRNSLaunch of New Advanced 3D Cardiotoxicity Model
6th Jul 201611:23 amRNSForm 8.3 - Cyprotex Plc
5th Jul 20163:17 pmRNSForm 8.3 - Cyprotex Plc
5th Jul 20169:36 amRNSForm 8.5 (EPT/RI)
4th Jul 20168:49 amRNSForm 8.5 (EPT/RI)
1st Jul 20169:25 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
30th Jun 20169:53 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
29th Jun 20168:56 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
28th Jun 20169:09 amPRNForm 8.3 - Cyprotex
28th Jun 20169:02 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
27th Jun 20169:02 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
23rd Jun 201612:15 pmRNSResult of AGM
23rd Jun 20167:00 amRNSLaunch of New Endocrine Disruption Service
22nd Jun 20169:25 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
21st Jun 201610:36 amRNSForm 8.5 (EPT/RI)
20th Jun 201610:56 amPRNForm 8.3 - Cyprotex Plc
16th Jun 20161:08 pmPRNForm 8.3 - Cyprotex plc
16th Jun 20167:00 amRNSLaunch of chemTarget
15th Jun 20169:03 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
13th Jun 20169:16 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
10th Jun 20168:50 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
9th Jun 20168:41 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
9th Jun 20167:00 amRNSPurchase of New IntelliCyt iQue Screener
8th Jun 20169:10 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
7th Jun 20162:26 pmRNSForm 8.3 - Cyprotex Plc
7th Jun 20168:57 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
6th Jun 20169:54 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
3rd Jun 20169:28 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
2nd Jun 20169:13 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.